ArticleScientific reports2025
Assessment of chemical risk factor for breast cancer based on gene expression profiles.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Breast cancer is one of the leading types of cancer diagnosis worldwide. Although the relationship between hormone exposure and breast cancer has been established, the role of environmental chemicals that induce alterations in mammary gland development and function remains understudied. This highlights the need for additional research into chemicals that may be involved in breast cancer progression. In this study, we analyzed transcriptomics data on MCF7 cell lines exposed to a set of 161 suspected mammalian carcinogens chemicals. From these data, we identified genes and pathways that impact the regulation of cellular proliferation and death processes, as well as cellular repair systems (regulation of the apoptotic process and cellular response to DNA damage stimuli). We also observed significant up-regulation of signaling pathways crucial to cancer development, such as the negative regulation of the MAPK cascade and the regulation of signal transduction by p53 class mediator. Furthermore, through an in vitro/ex vivo comparison, using RNA sequencing from 1,092 breast cancer tissues obtained from the TCGA-BRCA dataset, we identified a set of chemicals that share similar gene deregulation patterns with at least one patient. These compounds should be investigated further as they could be involved in breast cancer progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.